Regeneration Biomedical, Inc.
PrivateLast Round
Series B
Nov 10, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regeneration Biomedical, Inc. is a biotechnology company that develops direct-to-brain autologous stem cell therapies for the treatment of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regeneration Biomedical, Inc. Comparables
Compare Regeneration Biomedical, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UCB | 80% | |
| Aspen Neuroscience | 79% | |
| Oryon Cell Therapies | 79% | |
Regeneration Biomedical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 10, 2025 | ||||
| Series A | Jul 1, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 90% MoM.
- Jul 1, 2024
Completed a Series A funding round.
Regeneration Biomedical, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regeneration Biomedical, Inc.'s valuation, stock price, and market status.